Original paper

Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis

Volume: 9, Issue: 6, Pages: 305 - 305
Published: Jun 6, 2020
Abstract
Staphylococcus epidermidis is frequently implicated in medical device-related infections. As a result of this, novel approaches for control of this opportunistic pathogen are required. We examined the ability of the natural peptide nisin A, produced by Lactococcus lactis, to inhibit S. epidermidis. In addition, a bank of 29 rationally selected bioengineered L. lactis strains were examined with the aim of identifying a nisin derivative with...
Paper Details
Title
Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis
Published Date
Jun 6, 2020
Volume
9
Issue
6
Pages
305 - 305
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.